Page last updated: 2024-08-23

zidovudine and Lymphoma, B-Cell, Marginal Zone

zidovudine has been researched along with Lymphoma, B-Cell, Marginal Zone in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Carroll, SL; Jacobson, IV; Milross, CG; Post, JJ; Varma, R1

Other Studies

1 other study(ies) available for zidovudine and Lymphoma, B-Cell, Marginal Zone

ArticleYear
Combination antiretroviral therapy as treatment for human immunodeficiency virus-associated mucosa-associated lymphoid tissue type lymphoma of the nasopharynx.
    Internal medicine journal, 2011, Volume: 41, Issue:5

    Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Humans; Lamivudine; Lopinavir; Lymphoma, AIDS-Related; Lymphoma, B-Cell, Marginal Zone; Male; Middle Aged; Nasopharyngeal Neoplasms; Pyrimidinones; Radiotherapy, Adjuvant; Remission Induction; Ritonavir; Viral Load; Zidovudine

2011